Sio Capital Management as of March 31, 2026
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 76 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Maximus (MMS) | 7.1 | $49M | 769k | 64.10 | |
| Waystar Holding Corp (WAY) | 5.7 | $40M | 1.6M | 24.11 | |
| Icon SHS (ICLR) | 4.9 | $34M | 306k | 110.66 | |
| AmerisourceBergen (COR) | 4.5 | $32M | 101k | 314.14 | |
| Dianthus Therapeutics (DNTH) | 4.5 | $31M | 370k | 83.92 | |
| Anteris Technologies Global (AVR) | 4.3 | $30M | 5.4M | 5.55 | |
| Corcept Therapeutics Incorporated (CORT) | 3.9 | $27M | 675k | 40.31 | |
| Livanova SHS (LIVN) | 3.8 | $27M | 422k | 63.56 | |
| Tyra Biosciences (TYRA) | 3.3 | $23M | 605k | 38.30 | |
| Celcuity (CELC) | 3.2 | $22M | 194k | 114.14 | |
| GSK Sponsored Adr (GSK) | 3.1 | $21M | 386k | 55.19 | |
| Biosante Pharmaceuticals (ANIP) | 2.9 | $20M | 266k | 76.90 | |
| Abbott Laboratories (ABT) | 2.7 | $19M | 187k | 102.67 | |
| Embecta Corp Common Stock (EMBC) | 2.3 | $16M | 1.8M | 8.84 | |
| Abivax Sa Sponsored Ads (ABVX) | 2.2 | $15M | 136k | 111.35 | |
| Vir Biotechnology (VIR) | 1.9 | $13M | 1.5M | 8.96 | |
| Haemonetics Corporation (HAE) | 1.8 | $12M | 221k | 56.36 | |
| Sionna Therapeutics (SION) | 1.7 | $12M | 294k | 40.09 | |
| Sanofi Sa Sponsored Adr (SNY) | 1.7 | $12M | 240k | 48.18 | |
| Rapport Therapeutics (RAPP) | 1.6 | $12M | 367k | 31.29 | |
| Teleflex Incorporated (TFX) | 1.6 | $11M | 95k | 119.61 | |
| BioMarin Pharmaceutical (BMRN) | 1.6 | $11M | 194k | 56.49 | |
| Cross Country Healthcare (CCRN) | 1.5 | $10M | 1.1M | 9.40 | |
| Protara Therapeutics Com Stk (TARA) | 1.5 | $10M | 2.0M | 5.21 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 1.4 | $10M | 209k | 48.20 | |
| Biohaven (BHVN) | 1.4 | $9.8M | 1.2M | 8.46 | |
| Monopar Therapeutics Com New (MNPR) | 1.4 | $9.5M | 174k | 54.79 | |
| Eyepoint Com New (EYPT) | 1.3 | $9.3M | 722k | 12.89 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.3 | $9.1M | 250k | 36.32 | |
| Edgewise Therapeutics (EWTX) | 1.2 | $8.5M | 269k | 31.50 | |
| Compass Pathways Sponsored Ads (CMPS) | 1.2 | $8.3M | 1.5M | 5.53 | |
| Ocular Therapeutix (OCUL) | 1.2 | $8.2M | 969k | 8.47 | |
| Aquestive Therapeutics (AQST) | 1.1 | $8.0M | 1.9M | 4.15 | |
| Relmada Therapeutics (RLMD) | 1.0 | $6.7M | 965k | 6.96 | |
| Oruka Therapeutics (ORKA) | 0.9 | $6.5M | 133k | 49.05 | |
| Zenas Biopharma (ZBIO) | 0.9 | $6.5M | 332k | 19.55 | |
| Bright Minds Biosciences Com New (DRUG) | 0.9 | $6.3M | 86k | 72.97 | |
| Quidel Corp (QDEL) | 0.8 | $5.9M | 359k | 16.43 | |
| Zimmer Holdings (ZBH) | 0.8 | $5.7M | 63k | 90.42 | |
| Replimune Group (REPL) | 0.8 | $5.5M | 720k | 7.65 | |
| Organon & Co Common Stock (OGN) | 0.7 | $5.2M | 866k | 5.99 | |
| Onkure Therapeutics Com Cl A (OKUR) | 0.6 | $4.5M | 1.1M | 4.14 | |
| Disc Medicine (IRON) | 0.6 | $4.2M | 65k | 63.94 | |
| Pmv Pharmaceuticals (PMVP) | 0.5 | $3.8M | 3.1M | 1.24 | |
| Immunome (IMNM) | 0.5 | $3.6M | 165k | 21.87 | |
| Integra Lifesciences Hldgs C Com New (IART) | 0.5 | $3.6M | 383k | 9.42 | |
| Savara (SVRA) | 0.5 | $3.4M | 614k | 5.46 | |
| Centene Corporation Put Option (CNC) | 0.5 | $3.3M | 100k | 32.74 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 0.5 | $3.2M | 2.0M | 1.62 | |
| Shoulder Innovations Common Stock (SI) | 0.4 | $3.1M | 211k | 14.53 | |
| Ovid Therapeutics (OVID) | 0.4 | $2.8M | 1.3M | 2.22 | |
| Kymera Therapeutics (KYMR) | 0.4 | $2.7M | 32k | 83.29 | |
| Aligos Therapeutics Com New (ALGS) | 0.3 | $2.4M | 327k | 7.43 | |
| Context Therapeutics (CNTX) | 0.3 | $2.4M | 918k | 2.62 | |
| An2 Therapeutics (ANTX) | 0.3 | $2.2M | 657k | 3.42 | |
| Serina Therapeutics Com Shs (SER) | 0.3 | $1.9M | 1.0M | 1.94 | |
| Ibio Com New (IBIO) | 0.2 | $1.7M | 904k | 1.90 | |
| Adagio Med Hldgs (ADGM) | 0.2 | $1.5M | 1.3M | 1.15 | |
| Xilio Therapeutics (XLO) | 0.2 | $1.3M | 153k | 8.41 | |
| Bridgebio Oncology Therapeut Com New (BBOT) | 0.2 | $1.2M | 131k | 8.95 | |
| Hyperfine Com Cl A (HYPR) | 0.2 | $1.1M | 1.0M | 1.08 | |
| Senseonics Hldgs (SENS) | 0.1 | $771k | 116k | 6.66 | |
| Foghorn Therapeutics (FHTX) | 0.1 | $587k | 123k | 4.78 | |
| Terns Pharmaceuticals (TERN) | 0.1 | $533k | 10k | 52.72 | |
| Enanta Pharmaceuticals (ENTA) | 0.1 | $505k | 40k | 12.63 | |
| Tela Bio (TELA) | 0.1 | $395k | 636k | 0.62 | |
| Neuroone Med Technologies Com New | 0.1 | $386k | 497k | 0.78 | |
| Boundless Bio (BOLD) | 0.0 | $180k | 164k | 1.10 | |
| Nyxoah S A SHS (NYXH) | 0.0 | $148k | 51k | 2.92 | |
| Modular Med Com New (MODD) | 0.0 | $138k | 26k | 5.28 | |
| Elicio Therapeutics Put Option (ELTX) | 0.0 | $125k | 12k | 10.69 | |
| Erasca (ERAS) | 0.0 | $81k | 5.0k | 16.18 | |
| Oscar Health Cl A Put Option (OSCR) | 0.0 | $34k | 3.0k | 11.47 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $7.0k | 400k | 0.02 | |
| Humacyte *w Exp 08/27/202 (HUMAW) | 0.0 | $4.6k | 50k | 0.09 | |
| Simulations Plus (SLP) | 0.0 | $2.4k | 200.00 | 11.82 |